BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22330994)

  • 1. Prognostic significance of p16 expression in advanced cervical cancer treated with definitive radiotherapy.
    Schwarz JK; Lewis JS; Pfeifer J; Huettner P; Grigsby P
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):153-7. PubMed ID: 22330994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
    Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
    Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low P16
    Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation.
    Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p16 protein and epidermal growth factor receptor in patients with adenocarcinoma of the uterine cervix: an immunohistochemical analysis.
    Bodner K; Laubichler P; Kimberger O; Czerwenka K; Zeillinger R; Bodner-Adler B
    Arch Gynecol Obstet; 2011 Mar; 283(3):611-6. PubMed ID: 20405295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive STAT5 activation correlates with better survival in cervical cancer patients treated with radiation therapy.
    Chen HH; Chou CY; Wu YH; Hsueh WT; Hsu CH; Guo HR; Lee WY; Su WC
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):658-66. PubMed ID: 21300446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral metabolic heterogeneity of cervical cancer.
    Kidd EA; Grigsby PW
    Clin Cancer Res; 2008 Aug; 14(16):5236-41. PubMed ID: 18698042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.
    Yoo J; Choi JY; Moon SH; Bae DS; Park SB; Choe YS; Lee KH; Kim BT
    Int J Gynecol Cancer; 2012 Sep; 22(7):1226-33. PubMed ID: 22810970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
    Jedpiyawongse A; Homcha-em P; Karalak A; Srivatanakul P
    Asian Pac J Cancer Prev; 2008; 9(4):625-30. PubMed ID: 19256750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of p16 protein in the managementof cervical dysplasia].
    Pešek M; Kinkorová I; Ferko R; Urgeová A; Bouda J
    Ceska Gynekol; 2013 Apr; 78(2):195-9. PubMed ID: 23710985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status.
    Shonka DC; Shoushtari AN; Thomas CY; Moskaluk C; Read PW; Reibel JF; Levine PA; Jameson MJ
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1126-32. PubMed ID: 19917926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
    Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography.
    Yoon MS; Ahn SJ; Nah BS; Chung WK; Song HC; Yoo SW; Song JY; Jeong JU; Nam TK
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e491-7. PubMed ID: 22818418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/CT Response Criteria (European Organization for Research and Treatment of Cancer) Predict Survival Better Than Response Evaluation Criteria in Solid Tumors in Locally Advanced Cervical Cancer Treated With Chemoradiation.
    Yoon JW; Kim S; Kim SW; Kim YT; Kang WJ; Nam EJ
    Clin Nucl Med; 2016 Sep; 41(9):677-82. PubMed ID: 27276204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of p16 in locally advanced squamous cell carcinoma of the head and neck treated with concurrent cisplatin and radiotherapy.
    Lau HY; Brar S; Klimowicz AC; Petrillo SK; Hao D; Brockton NT; Kong CS; Lees-Miller SP; Magliocco AM
    Head Neck; 2011 Feb; 33(2):251-6. PubMed ID: 20848448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?
    Akkas BE; Demirel BB; Dizman A; Vural GU
    Ann Nucl Med; 2013 Oct; 27(8):756-63. PubMed ID: 23793926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer.
    Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutic S; Mutch DG; Powell MA; Grigsby PW
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1085-91. PubMed ID: 19880262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16 expression in patients with cervical cancer and its prognostic significance: meta-analysis of published literature.
    Huang K; Li LA; Meng YG; Fu XY
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():64-9. PubMed ID: 25461355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.